Stock listing
NASDAQ:ZYME Zymeworks Inc. Stock
Home listing (NASDAQ) of Zymeworks Inc.
Follow Zymeworks Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ZYME
$26.14 USD +0.10 (+0.4%)
Close on Nov 20, 2026
- Day range
- $26.09 – $27.56 USDNov 20, 2026
- Volume
- 738,813 sharesNov 20, 2026
- Market cap
- $1.84B USDAt the close on Nov 20, 2026 · price × 70.48M shares outstanding
- 52-week range
- $21.52 – $31.96 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $29.15M USDMedian day 844,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ZYME · Home | $26.14 USD | +0.10 (+0.4%) | 738,813 | $26.30 | $27.56 | $26.09 | $26.04 | Close on Nov 20, 2026 |
| Frankfurt:ZA8 | €23.07 EUR | +0.26 (+1.1%) | — | €23.46 | €23.46 | €23.07 | €22.81 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ZYME · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.14 | +0.10 | +0.4% | $26.30 | $27.56 | $26.09 | 738,813 | |
| $26.04 | +0.20 | +0.8% | $25.65 | $26.24 | $24.88 | 1,022,764 | |
| $25.84 | -0.61 | -2.3% | $26.45 | $26.52 | $25.53 | 569,917 | |
| $26.45 | +0.21 | +0.8% | $27.47 | $27.74 | $26.35 | 905,093 | |
| $26.24 | -0.23 | -0.9% | $26.47 | $26.75 | $25.82 | 770,307 | |
| $26.47 | -2.60 | -8.9% | $28.92 | $28.92 | $26.43 | 1,251,861 | |
| $29.07 | -2.39 | -7.6% | $31.94 | $31.94 | $28.92 | 898,576 | |
| $31.46 | +0.65 | +2.1% | $31.15 | $31.96 | $30.73 | 1,686,987 | |
| $30.81 | +1.18 | +4.0% | $30.00 | $30.88 | $29.66 | 1,107,990 | |
| $29.63 | +0.895 | +3.1% | $28.74 | $29.92 | $28.40 | 903,143 | |
| $28.74 | -2.205 | -7.1% | $30.85 | $30.85 | $28.72 | 1,222,507 | |
| $30.94 | +0.81 | +2.7% | $30.79 | $31.49 | $30.51 | 1,046,409 | |
| $30.13 | +1.14 | +3.9% | $29.41 | $30.39 | $29.29 | 2,519,221 | |
| $28.99 | +0.38 | +1.3% | $28.69 | $29.20 | $28.27 | 1,077,080 | |
| $28.61 | -0.10 | -0.3% | $28.81 | $29.02 | $28.26 | 2,290,788 | |
| $28.71 | -0.19 | -0.7% | $29.20 | $29.50 | $28.53 | 806,168 | |
| $28.90 | +0.05 | +0.2% | $28.54 | $29.47 | $28.54 | 833,140 | |
| $28.85 | +0.48 | +1.7% | $28.21 | $29.17 | $27.96 | 1,089,797 | |
| $28.37 | +0.15 | +0.5% | $28.36 | $28.50 | $27.59 | 832,193 | |
| $28.22 | -0.22 | -0.8% | $28.77 | $28.77 | $27.28 | 1,123,500 | |
| $28.44 | +0.325 | +1.2% | $28.12 | $28.97 | $27.99 | 757,300 | |
| $28.12 | +1.205 | +4.5% | $26.96 | $28.27 | $26.90 | 1,318,800 | |
| $26.91 | +1.37 | +5.4% | $25.76 | $27.20 | $25.71 | 3,130,300 | |
| $25.54 | +0.51 | +2.0% | $25.06 | $25.75 | $25.06 | 2,039,900 | |
| $25.03 | -0.72 | -2.8% | $25.67 | $25.86 | $24.94 | 632,800 | |
| $25.75 | +0.98 | +4.0% | $25.19 | $26.21 | $25.18 | 751,900 | |
| $24.77 | -0.30 | -1.2% | $25.00 | $25.20 | $24.60 | 558,800 | |
| $25.07 | -0.26 | -1.0% | $25.04 | $25.60 | $24.92 | 2,455,300 | |
| $25.33 | -0.46 | -1.8% | $25.56 | $25.79 | $25.19 | 2,775,800 | |
| $25.79 | +0.53 | +2.1% | $25.28 | $26.34 | $25.28 | 491,100 | |
| $25.26 | -1.27 | -4.8% | $26.24 | $26.24 | $25.00 | 1,367,200 | |
| $26.53 | +0.88 | +3.4% | $25.75 | $27.02 | $25.17 | 1,620,500 | |
| $25.65 | -0.56 | -2.1% | $26.42 | $26.79 | $25.51 | 1,466,000 | |
| $26.21 | +1.06 | +4.2% | $25.37 | $26.51 | $25.28 | 1,037,000 | |
| $25.15 | -0.81 | -3.1% | $26.18 | $26.19 | $25.04 | 844,400 | |
| $25.96 | -0.53 | -2.0% | $26.44 | $26.56 | $25.88 | 808,700 | |
| $26.49 | -0.71 | -2.6% | $27.25 | $27.73 | $26.47 | 1,585,000 | |
| $27.20 | +0.08 | +0.3% | $27.12 | $28.26 | $26.76 | 999,900 | |
| $27.12 | +0.60 | +2.3% | $25.94 | $27.54 | $25.66 | 1,375,700 | |
| $26.52 | -0.29 | -1.1% | $26.86 | $26.88 | $26.23 | 1,094,700 | |
| $26.81 | -0.69 | -2.5% | $27.13 | $27.50 | $26.14 | 752,900 | |
| $27.50 | -0.065 | -0.2% | $27.55 | $27.89 | $26.53 | 647,700 | |
| $27.57 | +0.755 | +2.8% | $26.72 | $27.70 | $26.55 | 446,000 | |
| $26.81 | +0.24 | +0.9% | $26.84 | $27.17 | $26.19 | 582,600 | |
| $26.57 | -0.91 | -3.3% | $27.45 | $27.55 | $26.38 | 1,096,100 | |
| $27.48 | +1.24 | +4.7% | $27.15 | $27.86 | $26.72 | 1,330,300 | |
| $26.24 | +0.19 | +0.7% | $26.17 | $26.55 | $25.91 | 687,000 | |
| $26.05 | -0.80 | -3.0% | $26.61 | $26.79 | $25.81 | 552,100 | |
| $26.85 | +0.61 | +2.3% | $26.80 | $27.14 | $26.23 | 711,000 | |
| $26.24 | -0.195 | -0.7% | $26.62 | $26.99 | $26.03 | 1,030,800 | |
| $26.44 | -0.715 | -2.6% | $26.81 | $27.04 | $26.39 | 585,300 | |
| $27.15 | -0.96 | -3.4% | $27.81 | $28.09 | $27.08 | 395,800 | |
| $28.11 | -1.08 | -3.7% | $28.93 | $28.93 | $28.07 | 442,400 | |
| $29.19 | -0.71 | -2.4% | $29.81 | $29.99 | $29.09 | 476,600 | |
| $29.90 | -1.15 | -3.7% | $31.34 | $31.34 | $29.59 | 790,900 | |
| $31.05 | +1.38 | +4.7% | $30.00 | $31.17 | $30.00 | 807,900 | |
| $29.67 | +0.26 | +0.9% | $29.32 | $29.90 | $29.08 | 483,000 | |
| $29.41 | +1.14 | +4.0% | $28.06 | $29.70 | $27.81 | 716,200 | |
| $28.27 | -0.74 | -2.6% | $28.91 | $28.91 | $28.18 | 542,100 | |
| $29.01 | -0.295 | -1.0% | $29.33 | $29.58 | $28.53 | 625,200 | |
| $29.31 | +1.835 | +6.7% | $27.56 | $30.62 | $27.48 | 1,215,700 | |
| $27.47 | -1.30 | -4.5% | $28.86 | $30.50 | $25.61 | 2,076,600 | |
| $28.77 | +0.10 | +0.3% | $28.68 | $28.83 | $27.01 | 823,000 | |
| $28.67 | +2.10 | +7.9% | $26.97 | $28.74 | $26.77 | 835,700 | |
| $26.57 | -0.64 | -2.4% | $27.08 | $27.16 | $26.24 | 498,700 |
- Ticker
- NASDAQ:ZYME
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
Latest earnings call · May 7, 2026
Zymeworks (NASDAQ:ZYME) Q1 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
European Society for Medical Oncology (ESMO) Meeting 2026
Conference · 8 slides
Calls
Replays
Zymeworks (NASDAQ:ZYME) Q1 2026 Earnings Call
Thu, May 07, 2026 · 4:30 PM ET
Watch TranscriptZymeworks (NASDAQ:ZYME) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 8:30 AM ET
Watch TranscriptZymeworks (NASDAQ:ZYME) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 4:30 PM ET
Watch Transcript
Latest news
Zymeworks Announces Participation in Upcoming Investor Conferences
Nov 19, 2026
Closed $26.14 (+0.4%) on Nov 20, 2026
Zymeworks Announces $200 Million Share Repurchase Authorization
Nov 16, 2026
Closed $26.45 (+0.8%) on Nov 16, 2026
Zymeworks Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Nov 9, 2026
Closed $31.46 (+2.1%) on Nov 10, 2026
Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors
Oct 27, 2026
Closed $28.85 (+1.7%) on Oct 27, 2026
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
Oct 24, 2026
Closed $28.37 (+0.5%) on Oct 26, 2026
Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3
Oct 23, 2026
Closed $28.22 (-0.8%) on Oct 23, 2026
Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
Oct 19, 2026
Closed $25.54 (+2.0%) on Oct 19, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
Oct 15, 2026
Closed $25.75 (+4.0%) on Oct 15, 2026
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition
Sep 28, 2026
Closed $27.12 (+2.3%) on Sep 28, 2026
Zymeworks Completes Acquisition of Theravance Biopharma
Sep 23, 2026
Closed $26.81 (-2.5%) on Sep 24, 2026
Financings
Non-recourse note
Jun 29, 2026
Announced: US$350M · TD Cowen
Dealers: TD Cowen
Buyers: OMERS Life Sciences ($350 million non-recourse note)
Use of proceeds: To finance the acquisition of Theravance Biopharma, Inc.
Non-recourse royalty-backed note
Mar 2, 2026
Update: US$250M · TD Cowen
Dealers: TD Cowen
Buyers: Royalty Pharma ($250 million royalty-backed note); Royalty Pharma plc ($250 million non-recourse royalty-backed note, repaid from 30% of worldwide tiered royalties on Ziihera)
Use of proceeds: Strengthen balance sheet, support stock repurchase program, potential strategic acquisitions and cash runway beyond 2028
Decks
European Society for Medical Oncology (ESMO) Meeting 2026
Conference · 8 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 31 slides · October 2026
Merger or Acquisition (June 2026)
Merger or acquisition · 17 slides · Jun 29, 2026
Q1 2026 Earnings Presentation
Earnings · 20 slides · May 7, 2026
Zymeworks Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 35 in the last 12 months · 172 in all · newest Nov 19, 2026 · oldest 2019
- Calls
- 14 calls with a replay · 14 with a transcript · latest May 7, 2026
- Decks
- 32 decks · latest October 2026
Where Zymeworks Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ZYME · Home listing · This page | NASDAQ | United States | USD |
| gettex:ZA8 | gettex | Germany | EUR |
| Lang & Schwarz:A3DSSN | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3DSSN | LS Exchange | Germany | EUR |
| Tradegate:ZA8 | Tradegate | Germany | EUR |
| BOATS:ZYME | BOATS | United States | USD |
| Dusseldorf:ZA8 | Dusseldorf | Germany | EUR |
| Frankfurt:ZA8 | Frankfurt | Germany | EUR |
| Hamburg:ZA8 | Hamburg | Germany | EUR |
| Munich:ZA8 | Munich | Germany | EUR |
| Stuttgart:ZA8 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Zymeworks Inc.